Patenton — panteon of patents

(19)

RU

(11)

2 306 952

(13)

C2

(51)

IPC

A61K39/395(2006-01-01)

C07K16/32(2006-01-01)

A61P35/00(2006-01-01)

(21) (22)

Application

2003104016/15, 2001-05-16

(24)

Start date

2001-05-16

(22)

Actual filing date

2001-05-16

(45)

Published

2007-09-27

(72)

Inventor

Khanna NabilKharikharan Kandasami

(73)

Holder

Bajodzhen Ajdek Ink.

METHOD FOR TREATING THE CASES OF MALIGNANT TUMORS CONTAINING B-CELLS WITH A COMBINATION OF APPLICATIONS RELATED TO ANTIBODIES REDUCING B-CELLS NUMBER AND WITH IMMUNOMODULATING ANTIBODIES Russian patent published in 2007 - IPC A61K39/395 C07K16/32 A61P35/00 

Abstract RU 2306952 C2

FIELD: medicine.

SUBSTANCE: method involves using immunoregulating antibody like antibody against B7, antibody against CD23 or antibody reducing B-cells number and antibody against CD20 first of all, in particular. The combined therapy preferably involves introducing antibody against B7 and antibody against CD20.

EFFECT: wide range of applications; enhanced effectiveness of treatment.

27 cl, 4 dwg, 3 tbl

Similar patents RU2306952C2

Title Year Author Number
COMBINATION OF ANTI-EDb FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND MOLECULE BINDING TO B-CELLS, B-CELL PROGENITORS AND/OR THEIR CANCEROUS COUNTERPART 2008
  • Neri Dario
  • Menssen Khans Ditrikh
  • Menrad Andreas
  • Shliman Kristof
 RU2484845C2
TREATMENT OF B-CELLULAR MALIGNANT TUMORS USING ANTI-CD40L ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES AND/OR BY CHEMOTHERAPY AND RADIOTHERAPY 2000
  • Khanna Nabil
  • Kharikharan Kandasami
 RU2305561C2
IMMUNOTHERAPY OF MALIGNANT DISEASES OF B-CELLS AND AUTOIMMUNE DISEASES WITH APPLICATION OF CONJUGATE AND NONCONJUGATE ANTIBODIES, COMBINATIONS OF ANTIBODIES AND CONJOINT PROTEINS 2003
  • Goldenberg Dehvid M.
  • Khansen Khans
 RU2335297C2
COMBINATION THERAPY WITH ANTI-CD19 ANTIBODY AND A PURINE ANALOG 2012
  • Amersdorffer Jutta
  • Steidl Stefan
  • Winderlich Mark
  • Krohn Susanne
  • Rojkjaer Lisa
 RU2664462C9
COMBINED THERAPY WITH AFUCOSYLATED CD20 ANTIBODY AND mTOR INHIBITOR 2011
  • Gerting Frank
  • Klyajn Kristian
 RU2585489C2
USING ANTI-CD40-ANTIBODIES 2008
  • Lukman Mokhammad
  • Van Junjuj
  • Kantak Sima
  • Khsu Ssuchehn Tsz.
  • Mirza Amer M.
 RU2491095C2
COMBINED THERAPY FOR TREATMENT OF AUTOIMMUNE DISEASES BY USING COMBINATION OF ELIMINATING B-CELLS AND IMMUNOREGULATORY ANTIBODIES 2001
  • Khanna Nabil
 RU2285541C2
COMBINED THERAPY BY AFUCOSYLATED ANTIBODY FOR CD20 WITH ANTIBODY FOR VEGF 2011
  • Gerting Frank
  • Klyajn Kristian
 RU2615459C2
USING ANTI-CD20 TYPE II ANTIBODY, HAVING HIGH ANTIBODY-INDUCED CELL-DEPENDENT CYTOTOXICITY (ADCC), COMBINED WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND DOXORUBICIN FOR TREATING NON-HODGKIN LYMPHOMAS 2009
  • Sharl Dyumonte
  • Tomas Friss
  • Frank Kherting
  • Kristian Klajn
  • Pablo Umana
 RU2589704C2
COMBINED THERAPY WITH CD19 ANTIBODY AND NITROGEN MUSTARD 2012
  • Amersdorfer Yutta
  • Shtajdl Shtefan
  • Vinderlikh Mark
  • Kron Suzanne
  • Rojker Liza
 RU2625222C2

RU 2 306 952 C2

Authors

Khanna Nabil

Kharikharan Kandasami

Dates

2007-09-27—Published

2001-05-16—Filed

download Download PDF read Similar patents